Protara Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update
Provided By GlobeNewswire
Last update: Nov 12, 2024
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today provided a business update and announced financial results for the third quarter ended September 30, 2024.
Read more at globenewswire.com
